Italy · biotech/health
Italy · biotech/healthGenenta Science
Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.
Public · NASDAQ:GNTAFor profit
Against its peers
Set against 621 biotech/health companies worldwide. The ring marks the typical peer.
Across all 5.9M companies: larger than 0% of those with a size listed; older than 5% of those with a founding year; website ranked #3,952,671 in the world, about 3k visits a month.
About Genenta Science
BiotechnologyClinical TrialsGeneticsHealth Care
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$34M
raised in total, currency not stated across 4 rounds
Last raised Dec 2021, 4 years ago
- Rounds
- 4
- Latest round
- Post ipo secondary
- Investors
- 53 leading
Key facts
Who started it and how it trades.
- Founded by
- Bernhard Gentner, Luigi Naldini, Pierluigi Paracchi
Every detail we hold
Everything the source datasets list about Genenta Science, field by field. Contact details are held but never shown.
The company7 fields
- Name
- Genenta Science
- Type
- For profit
- Status
- Public · NASDAQ:GNTA
- Founded
- 2014
- Founders
- Bernhard Gentner, Luigi Naldini, Pierluigi Paracchi
- Industry
- biotech/health
- Categories
- Biotechnology, Clinical Trials, Genetics, Health Care
Where3 fields
- City
- Milano
- Country
- Italy
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach3 fields
- Staff band
- 1-10
- Web traffic rank
- #3,952,671
- Monthly web visits
- 2,799
Show 10 more fieldsShow fewer fields
Funding, as listed8 fields
- Total
- 33,937,909 (currency not stated)
- Rounds
- 4
- Latest round
- Post ipo secondary
- Latest round date
- Dec 2021
- Investors
- 5
- Lead investors
- 3
- Stock listing
- NASDAQ:GNTA
- Listing status
- public
About this record2 fields
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Genenta Science may be growing as the company appears to be in a good position to invest in growth, which suggests a solid financial foundation and potential for expansion. The fact that individual investors account for a significant portion of the company's ownership indicates a broad base of support and confidence in its prospects. Furthermore, the involvement of insiders in the ownership structure can be a positive sign of commitment to the company's success.
Companies like Genenta Science
biotech/health in Italy.
Build a lead list
Every biotech/health company, filtered by size, age and reach, ready to export with emails on Pro.